The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Clinics in Liver Disease

Volumn 8, Issue 3, 2004, Pages 521-533

  McCullough, Arthur J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIODARONE; CORTICOSTEROID; ESTROGEN; INSULIN; NIFEDIPINE; PERHEXILINE;

ALCOHOL CONSUMPTION; BLOOD CHEMISTRY; CLINICAL FEATURE; CONSENSUS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; EPIDEMIC; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FIBROSIS; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PREDICTION; PREVALENCE; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SCREENING; SERUM; SURGICAL TECHNIQUE;

ADULT; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 4344628555     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.04.004     Document Type: Review

References (102)

1. Falck-Ytter Y., Younossi Z.M., Marchesini G., McCullough A.J. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2:2001;17-26
2. Clark J.M., Diehl A.M. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology. 24:2003;248-250
3. Seidell J.C. Obesity, insulin resistance and diabetes - a world wide epidemic. Br J Nutr. 83(Suppl 1):2000;55-58
4. Ludwig J., Viggiano T.R., McGill D.B., Ott B.J. Nonalcoholic steatohepatitis. Mayo Clinic experience with a hither to unnamed disease. Mayo Clin Proc. 55:1980;434-438
5. Bacon B.R., Farahvash M.J., Janney C.G., Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 107:1994;1103-1109
6. Youssef W.I., McCullough A.J. Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol. 16:2002;733-747
7. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 123:2002;1705-1725
8. Matteoni C.A., Younossi Z.M., Gramlich T., Bopari N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116:1999;1413-1419
9. Charlton M., Kasparova P., Weston S., Lindor K., Maor-Kendler Y., Wiesner R.H., et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 7:2001;608-614
10. Ratzin V., Bonyhay L., Di Martino V., Charlotte F., Cavallaro L., Sayegh-Tainturier M.H., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 35:2002;1485-1493
11. Hui J.M., Kench J.G., Chitturi S., Sud A., Farrell G.C., Byth K., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis c. Hepatology. 38:2003;420-427
12. Youssef W., McCullough A.J. Diabetes mellitus, obesity and hepatic steatosis. Semin Gastrointest Dig. 13:2002;7-30
13. McCullough A.J. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 34:2002;155-162
14. Angulo P., Keach J.C., Batts K.P., Lindor K.D. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology. 30:1999;1356-1362
15. Lee R.G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 20:1989;594-598
16. Diehl A.M., Goodman Z., Ishak K.G. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 95:1988;1056-1062
17. Powell E.E., Cooksley W.G.E., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 11:1990;74-80
18. Teli M.R., James O.F.W., Burt A.D., Bennett M.K., Day C.P. The natural history of nonalcoholic fate liver: a fellow-up study. Hepatology. 22:1995;1714-1719
19. Bellentani S., Saccoccio G., Masatti F., Bruce L.S., Brand G., Sasso F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 132:2000;112-117
20. George D.K., Goldwurm S., MacDonald G.A., Cowley L.L., Walker N.I., Ward P.J., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 114:1998;311-318
21. Bonkovsky H.L., Jawhid Q., Tortorelli K., LeClair P., Cobb J., Lambrecht R.W., et al. Nonalcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in nonalcoholic steatohepatitis. J Hepatol. 31:1999;421-429
22. Nair S., Cope K., Terrence R.H. Obesity and female gender increase breath ethanol concentration and potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol. 96:2001;1200-1204
23. Hu F.B., Manson J.E., Stampfer M.J. Diet, lifestyle and the risk of type 2 diabetes in women. N Engl J Med. 345:2001;790-797
24. Dixon J.R., Bathol P.S., O'Brien P.E. Nonalcoholic fatty liver disease. Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 12:2001;91-100
25. Dasarthy S., McCullough A.J. Alcohol-induced liver injury. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's diseases of the liver. 9th edition:2002;1019-1057 Lippincott Raven, Philadelphia
26. Propst A., Propst T., Judmaier G., Wolfgang V. Prognosis in nonalcoholic steatohepatitis. Gastroenterology. 108:1995;1607
27. Cortez-Pinto H., Baptista A., Camillo M.E., DeMoura M.C. Nonalcoholic steatohepatitis - a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 48:2003;1909-1913
28. Younossi Z.M., Gramlich T., Lui Y.C., Petrelli M., Goldblum J., McCullough A.J. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol. 11:1998;560-565
29. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 94:1999;2467-2474
30. Sheth S.G., Gordon F.D., Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;136-145
31. Harrison S.A., Torgerson S., Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 98:2003;2042-2047
32. Younossi Z.M., Gramlich T., Bacon B.R., Matteoni C.A., Bopari N., O'Neill R., et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 30:1999;847-850
33. Hui J.M., Kench J.G., Chitturi S., Sud A., Farrell G.C., Byth K., et al. Long term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 38:2003;420-427
34. Ratziu V., Bonyhay L., DiMartino V., Charlotte F., Cavallaro L., Sayegh-Tainturier M.H., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 35:2002;1485-1493
35. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 32:1999;689-692
36. Poonawala A., Nair S.P., Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 32:2000;689-692
37. Caldwell S.H., Hespenheide E.E. Subacute liver failure in obese women. Am J Gastroenterol. 97:2002;2058-2067
38. Bugianesi E., Leone A., Vanni E., Marchesini G., Brunello F., Carucci P., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123:2002;134-140
39. Shimada M., Hashimoto E., Taniai M., Hasegawa K., Okuda H., Hayashi N., et al. Hepatocellular in patients with nonalcoholic steatohepatitis. J Hepatol. 37:2002;154-160
40. Cotrim H.P., Parana R., Brago E., Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol. 95:2000;3018-3019
41. Zen Y., Katayanagi K., Tsuneyama K., Harada K., Araki I., Makanuma Y. Hepatocellular carcinoma arising in nonalcoholic steatohepatitis. Pathol Int. 51:2001;127-131
42. Nair S., Mason A., Eason J., Loss G., Perillo R.P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 76:2002;150-155
43. Ong J., Younossi Z.M., Reddy V., Price L.L., Gramich T., Mayes J., et al. Cryptogenic cirrhosis and post-transplantation nonalcoholic fatty liver disease. Liver Transpl. 7:2001;797-801
44. Contos M.J., Cales W., Sterling R.K., Luketic V.A., Shiffman M.L., Mills A.S., et al. Development of nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis. Liver Transpl. 7:2001;363-373
45. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1990;1106-1110
46. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodoron I., et al. Liver fibrosis in overweight patients. Gastroenterology. 118:2000;1117-1123
47. Garcia-Monzon C., Martin-Perez E., Iacono O.L. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 33:2000;716-724
48. Willner I.R., Waters B., Patil S.R., Reuben A., Morelli J., Riely C.A. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 96:2001;2957-2961
49. Harrison S.A., Oliver D.A., Torgerson S., Paul H., Neuschwander B.A. NASH: clinical assessment of 501 patients from two separate academic medical centers with validation of a clinical scoring system for advanced hepatic fibrosis. Hepatology. 34:2003;511A
50. Bianchi L. Liver biopsy in elevated liver function tests? An old question revisited. J Hepatol. 35:2001;290-294
51. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 123:2002;745-750
52. 1h spectroscopy: validation in vivo. Am J Physiol. 276:1999;E977-E989
53. Ricci C., Lungo R., Gioulis E., Bosco M., Pollesello P., Mustti F., et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 27:1997;108-113
54. Fishbein M.H., Gardner K.G., Potter C.J., Schmalbrock P., Smith M.A. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 15:1997;287-293
55. Levenson H., Greensite F., Hoefs J., Frilous L., Appelgate G., Silva E., et al. Fatty infiltration of the liver. Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR. 156:1991;307-312
56. Siegelman E.S., Rosen M.A. Imaging of hepatic steatosis. Semin Liver Dis. 21:2001;71-80
57. Longo R., Pollesello P., Ricci C., Masutti F., Kvam Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 4:1995;281-285
58. Jacobs J.E., Birnbaum B.A., Shapira M.A., Langlotz C.P., Slosman F., Rubesin S.E., et al. Diagnostic criteria for fatty infiltration of the liver on contrast enhanced helical CT. AJR. 171:1998;659-664
59. Hulcrantz R., Gabrielson N. Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med. 233:1993;7-12
60. Zweiman B., Parrott C.M., Graif Y., David M., Lessin S.R. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 35:2000;319-324
61. Graif M., Yanuka M., Baraz M. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 35:2000;319-324
62. Leevy C.M. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine (Baltimore). 4:1962;249-258
63. Mathieson N.L., Franzen L.E., Fryden A., Fuberg U., Bodenar G. The clinical significances of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol. 34:1999;55-91
64. Sorbi D., Boynton J., Lindor K.D. The ratio of aspartate amino transferase to alanine amino transferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 94:1999;1018-1022
65. Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol. 35:2001;195-199
66. Daniel S., Ben-Menachem T., Vasudevan G., Ma C.K., Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminases abnormalities in asymptomatic patients. Am J Gastroenterol. 94:1999;3010-3014
67. Prati D., Taioli E., Zanella A., Torre E.D., Butelli S., DelVecchio E., et al. Updated definitions of health ranges for serum amino transferase levels. Ann Intern Med. 137:2002;1-9
68. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology. 122:2002;1649-1657
69. Kumar K.S., Malet P.F. Nonalcoholic steatohepatitis. Mayo Clin Proc. 75:2000;733-739
70. Fargion S., Mattioli M., Francanzani A.L., Sampietro M., Tavazzi D., Fociani P., et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol. 96:2001;2448-2455
71. Fernandez-Real J.M., Casamitjana-Abella R., Ricart-Engel W., Cabrero D., Arroyo E., Fernandez-Castaner M., et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 21:1998;62-68
72. Itoh S., Yougel T., Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 82:1987;650-654
73. VanNess M.M., Diehl A.M. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med. III:1989;473-478
74. Pinto H.C., Baptista A., Camilo M.E., Valene A., Saragoca A., DeMoura M.C. Nonalcoholic steatohepatitis: clinicopathological comparison with alcohol hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 41:1996;172-179
75. Fletcher L.M., Knoh-Gain I., Powell L.W., Halliday J.W. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis. Hepatology. 13:1991;445-459
76. Czaja A.J., Carpenter H.A., Santrach P.J., Moore S.B. Genetic predispositions for immunological features in chronic liver disease other than autoimmune hepatitis. J Hepatol. 24:1996;52-59
77. Tajiri K., Takenawa H., Yamaoka K., Yamane M., Marumo F., Sato C. Nonalcoholic steatohepatitis masquerading as autoimmune hepatitis. J Clin Gastroenterol. 25:1997;538-540
78. Loria P., Lonardo A., Leonardi F., Fontana C., Carulli L., Verrone A.M., et al. Nonorgan-specific auto-antibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 48:2003;2173-2181
79. Yu A.S., Keefe E.B. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence? Am J Gastroenterol. 98:2003;955-956
80. Yu A.S., Keefe E.B. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord. 2:2002;11-19
81. Berasain C., Betes M., Panizo A., Ruiz J., Herrero J.L., Civeira M.P., et al. Pathological and virological findings in patients with persistent hypertransaminemia of unknown etiology. Gut. 47:2000;429-435
82. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med. 342:2000;1266-1271
83. Alba L.M., Lindor K. Review article: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 17:2003;977-986
84. Mofrad P., Contos M., Haque M., Sargeant C., Fisher R.A., Luketic V.A. Clinical and histologic spectrum of nonalcoholic fatty liver disease with normal ALT values. Hepatology. 37:2003;1286-1292
85. Noaguchi H., Tazawa Y., Nishinomiya F., Takada G. The relationship between serum transaminases activities and fatty liver in children with simple obesity. Acta Paediatr Jpn. 37:1995;621-625
86. Fong D.G., Nehra V., Lindor K., Buchman A.L. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology. 32:2000;3-10
87. Monto A., Alonzo J., Watson J.J., Grunfeld C., Wright T.L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes, and alcohol. Hepatology. 36:2002;729-736
88. Poynard T., Ratziu V., McHutchison J., Manns M., Goodman Z., Zeuzem S., et al. Effect of treatment with PEG interferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology. 38:2003;75-85
89. McCullough A.J. Obesity and its nurturing effect on hepatitis C. Hepatology. 38:2003;557-559
90. Bressler B.L., Guindi M., Tomlinson G., Heathcote J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology. 38:2003;639-644
91. Cortez-Pinto H., Camilo M.E., Baptista A., DeOliveira A.G., DeMoura M.C. Nonalcoholic fatty liver: another clinical feature of the metabolic syndrome? Clin Nutr. 18:1999;353-358
92. Laurin J., Lindor K.D., Crippin J., Gossard A., Gores G.J., Ludwig J., et al. Ursodeoxycholic acid or clobifrate in the treatment of nonalcohol-induced steatohepatitis: a pilot study. Hepatology. 23:1996;1464-1467
93. Cortez-Pinto H., Camilu M.E., Baptista A., DeOliveira A.G., DeMoura M.C. Nonalcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 18:1999;353-358
94. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 35:2002;373-379
95. Marchesini G., Bugianessi E., Forlani G., Ceprelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology. 37:2003;917-923
96. Baldridge A.D., Perez-Atayde A.R., Graeme-Cook F., Higgins L., Lavine J.E. Idiopathic steatohepatitis in childhood: a multi-center retrospective study. J Pediatr. 127:1994;700-704
97. Rashid M., Roberts E. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 30:2000;48-53
98. Franzese A., Vasjro P., Argenziano A., Puzziello A., Iannucci M.P., Saviano M.C., et al. Liver involvement in obese children: ultrasound and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 42:1997;1428-1432
99. Tuminaga K., Kurata J.H., Chen Y.K., Fujimoto E., Miyagawa S., Abe I., et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonography survey. Dig Dis Sci. 40:1995;2002-2009
100. Santos L., Molina E.G., Jeffers L.J., Reddy K.R., Schiff E.R. Prevalence of nonalcoholic steatohepatitis among ethnic groups (abstract). Gastroenterology. 54:2001;A630
101. Caldwell S.H., Harris D.M., Patrie J.T., Hespenheide E.E. Is NASH underdiagnosed among African Americans? Am J Gastroenterol. 97:2002;1496-1500
102. Struben V.M.D., Hespenheide E.E., Caldwell S. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med. 108:2000;9-13